Chronic myeloid leukemia (CML) is a hematopoietic stem cell (HSC) disease characterized by the translocation t(9;22)(q34;q11), resulting in the fusion of the BCR and ABL1 genes. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.